Discovery and Basic Research
Doug Krafte, PhD (he/him/his)
Sr. Vice President, Ion Channels/Transporters
OmniAb, Inc.
Durham, North Carolina
Description: Learn how an advanced technology platform enables companies to identify potential therapeutic candidates for the treatment of important unmet medical needs. For biologic therapeutical applications, the platform incorporates multiples species of transgenic animals, single B-cell screening and ion channel screening to characterize molecules and rapidly identify quality leads for advancement. The ion channel screening technology can also be utilized in small molecule discovery, which will be described in a case study regarding a project targeting chronic kidney disease.